Connor, Clark & Lunn Investment Management Ltd. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 87 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2023$134,002
+24.6%
84,278
-43.8%
0.00%0.0%
Q1 2023$107,507
-7.5%
149,856
-25.3%
0.00%0.0%
Q4 2022$116,183
-40.1%
200,489
-1.6%
0.00%0.0%
Q3 2022$194,000
+37.6%
203,725
+73.4%
0.00%0.0%
Q2 2022$141,000
-64.5%
117,512
-61.2%
0.00%
-50.0%
Q1 2022$397,000
-33.4%
302,717
-10.6%
0.00%
-33.3%
Q4 2021$596,000
-25.4%
338,740
-8.1%
0.00%
-25.0%
Q3 2021$799,000
+111.9%
368,405
+411.5%
0.00%
+100.0%
Q1 2019$377,000
+35.6%
72,025
-18.5%
0.00%0.0%
Q4 2018$278,000
-70.7%
88,325
-43.6%
0.00%
-60.0%
Q3 2018$948,000
+10.6%
156,650
-3.1%
0.01%0.0%
Q2 2018$857,000
-14.0%
161,650
-5.9%
0.01%
-16.7%
Q1 2018$996,000
+45.6%
171,750
-12.2%
0.01%
+50.0%
Q4 2017$684,000
-18.1%
195,550
-14.5%
0.00%
-20.0%
Q3 2017$835,000
+45.7%
228,750
-0.3%
0.01%
+25.0%
Q2 2017$573,000
-7.4%
229,3500.0%0.00%0.0%
Q1 2017$619,000
-7.3%
229,350
-0.4%
0.00%
-20.0%
Q4 2016$668,000
-38.0%
230,350
-12.2%
0.01%
-37.5%
Q3 2016$1,078,000
+12.8%
262,250
-13.3%
0.01%
+14.3%
Q2 2016$956,000302,4500.01%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 6,552,068$14,218,0008.03%
Versant Venture Management, LLC 5,068,233$10,998,0004.55%
K2 PRINCIPAL FUND, L.P. 1,653,874$3,589,0000.29%
RTW INVESTMENTS, LP 7,483,757$16,240,0000.24%
Avoro Capital Advisors LLC 6,950,000$15,082,0000.24%
Artal Group S.A. 3,000,000$6,510,0000.15%
ALGERT GLOBAL LLC 231,490$502,0000.07%
Virtus ETF Advisers LLC 57,768$125,0000.06%
Pinz Capital Management, LP 53,600$116,0000.05%
TWIN FOCUS CAPITAL PARTNERS, LLC 100,000$217,0000.05%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders